Evaluation of the Impact of Pancreatectomy on Systemic Immunity
Launched by INSTITUT PAOLI-CALMETTES · Jun 5, 2019
Trial Information
Current as of July 08, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with an indication of pancreatectomy
- • Signed consent form
- Exclusion Criteria:
- • Neoadjuvant treatment
- • Pregnancy
About Institut Paoli Calmettes
Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Marseille, Provence Alpes Côte D'azur, France
Patients applied
Trial Officials
Olivier Turrini, MD ¨PhD
Principal Investigator
Institut Paoli-Calmettes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials